Delivery Order SPE2DB20D3505-SPE2DB23FT8J8
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,472.71 firm fixed-price delivery order covers the supply of Depakote DR 125 mg sprinkle capsules. The contract has an ultimate completion date of March 22, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,207.01 firm fixed-price delivery order is for the supply of 4,568,106,903 units of the medication Depakote DR 125 mg sprinkle capsules. The contract has a performance period through May 2, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.29 firm fixed-price contract is for the delivery of Depakote DR 125 mg medication sprinkle capsules. It is an open competition contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,090.64, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA. The IDC, worth up to $999,999,999, provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,582.63, is a Firm Fixed Price Delivery Order for 4567854243 ! DEPAKOTE DR 125 MG SPRINKLE CP 100S. The contract has an ultimate completion date of April 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for a delivery order (SPE2DB23FP8J4) issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,253.85 firm fixed-price contract is for the supply of DEPAKOTE DR 125 MG SPRINKLE CP 100S, a medication used to treat various medical conditions. The contract has an ultimate completion date of September 25, 2023. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,548,337 units of the medication Depakote DR 125 mg sprinkle capsules, with an ultimate completion date of June 16, 2025 and a ceiling value of $2,055.23. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Depakote DR 125 mg Sprinkle capsules (100-count packaging) with a ceiling value of $1,921.72. The award was made on July 30, 2025, with a completion date of July 31, 2025, under a firm fixed-price delivery order contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work at its corporate office location. This delivery order...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,182.62 firm fixed-price delivery order contract is for the supply of Depakote DR 250 mg tablets. The contract has an ultimate completion date of August 24, 2022 and was awarded on August 23, 2022. This award is a part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,328.59 firm fixed-price delivery order covers the supply of DEPAKOTE DR 250 MG TABLET 100S, a medication used to treat certain types of seizures. The award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB23FT8J8Delivery Order
This federal contract award, valued at $2,279.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Depakote DR 125 mg sprinkle capsules over the period ending on March 14, 2023. This is a delivery order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company, Cencora, Inc., also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 3/13/23 |